HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and endocrine aspects of pituitary tumors.

AbstractOBJECTIVE:
To study the clinical spectrum and endocrine profile of pituitary tumors presenting to a tertiary care endocrine center.
METHODS:
Retrospective analysis of clinical and hormonal data of patients with pituitary tumors admitted in the Endocrinology Department of Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir India between January 1989 and December 1998.
RESULTS:
Over a period of one decade, 75 subjects were diagnosed to have pituitary tumors. Somatotroph adenoma was the most common pituitary mass lesion seen (44/75) and followed in the decreasing order of frequency, by non-functioning pituitary tumor (12/75), prolactinoma (11/75) and corticotroph adenoma (8/75). Overall there was a male preponderance (male to female ratio was 41:34). Subjects with somatotroph adenoma presented with classical features of acromegaly: mean fasting and post glucose suppression growth hormone levels were 34.04+/-11.67 and 36.47+/-6.64 ng/ml. Eleven subjects (9 females and 2 males) had prolactinoma; females presented with the classical symptom complex of amenorrhea-galactorrhea while males presented with headache, visual disturbances and impotence. The 12 subjects with nonfunctioning pituitary tumors presented with features of mass lesion. Of the 8 subjects (6 females and 2 males) with corticotroph adenomas, 2 were confirmed to have periodic hormonogenesis.
CONCLUSION:
In an endocrine center, functioning pituitary tumors are more often seen than non-functioning tumors.
AuthorsAbdul H Zargar, Bashir A Laway, Shariq R Masoodi, Mohammad Salahuddin, Mohammad A Ganie, Mohammad H Bhat, Arshad I Wani, Mir I Bashir
JournalSaudi medical journal (Saudi Med J) Vol. 25 Issue 10 Pg. 1428-32 (Oct 2004) ISSN: 0379-5284 [Print] Saudi Arabia
PMID15494816 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adenoma (diagnosis, epidemiology, therapy)
  • Adenoma, Chromophobe (diagnosis, epidemiology, therapy)
  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Female
  • Humans
  • India (epidemiology)
  • Male
  • Middle Aged
  • Pituitary Neoplasms (diagnosis, epidemiology, therapy)
  • Prevalence
  • Prognosis
  • Prolactinoma (diagnosis, epidemiology, therapy)
  • Retrospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: